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DEEP HYPOTHERMIC CIRCULATORY ARREST EFFECTIVELY PRESERVES 
NEUROCOGNITIVE FUNCTION. 
Katherine H. Chau, Tamir Friedman, Maryann Tranquilli, John A. Elefteriades. Section 
of Cardiothoracic Surgery, Yale University School of Medicine, New Haven, CT. 
 
Few (conflicting) studies have quantitatively assessed neurocognitive effects of 
deep hypothermic circulatory arrest (DHCA), and even fewer have looked at the long-
term effects of DHCA. In this study, we aim to determine if DHCA negatively affects 
neurocognitive function and if so, are the effects long-term. We assess neurocognitive 
function quantitatively before and after DHCA and also in comparison with non-DHCA 
patients.  62 aortic surgical patients underwent a battery of neuropsychometric tests, both 
pre and post-operatively, evaluating multiple aspects of memory, processing speed, 
executive function, and global cognition. 33 patients did not require DHCA, and 29 
underwent DHCA as the sole means of cerebral protection. Of these, 19 patients who 
tested positive for cognitive deficits, 8 of whom underwent DHCA and 11 who did not, 
were followed long-term with an additional testing months to years post-operatively. 
“Neurocognitive deficit” was defined as greater than 20% decline in two or more 
cognitive areas. Pre and post-operative test scores, as well as incidence of 
“neurocognitive deficit”, were compared within each group (post versus pre-operatively), 
and between the non-DHCA and DHCA groups. There were no significant differences in 
the post versus pre-operative scores in any cognitive area tested between DHCA and non-
DHCA groups. There was also no difference between the two groups in incidence of 
“neurocognitive deficit”: 13 non-DHCA, 11 DHCA (p = 1.00). In addition, there was no 
correlation between time under DHCA and incidence of “neurocognitive deficit”. Within 
both groups, there was a mild decline in memory in the areas of acquisition, retention, 
	  
and delayed recall. Within the DHCA group, recognition was also affected. Time under 
DHCA up to 40 minutes was also found to be safe neurocognitively. Of the 24 patients 
that who incurred a “neurocognitive deficit,” 19 participated in further follow-up, and of 
these, 4 DHCA and 2 non-DHCA patients had persistent memory deficits (p = 0.32). 
There was also no statistically significant difference in duration under DHCA between 
those who did or did not recover from their deficits (p = 0.56). DHCA patients who did 
have persistent memory deficits tended to have additional aspects of memory become 
affected when tested at further follow-up. There was a statistically significant difference 
in age, above or below 70 years old, between patients whose memory deficits persisted or 
recovered (p < 0.001). While cardiac surgery had some effects on memory, overall 
neurocognitive function was well preserved and did not differ between DHCA and non-
DHCA patients. DHCA does not affect whether or not memory deficits incurred post-
operatively persist, but in those patients who underwent DHCA whose memory deficits 
did persist, those deficits tended to affect additional memory aspects that on previous 
testing had not been affected. What does affect the temporal nature of memory deficits is 
age, with patients over the age of 70 having a higher incidence of persistent long-term 
memory deficits. This study provides strong evidence that straight DHCA effectively 








 I would like to express my utmost gratitude to Dr. John A. Elefteriades who has 
provided invaluable support and guidance since the very beginning of this study, and 
without whom I would never have been able to carry this out.  
 I would also like to thank the Yale School of Medicine Office of Student 
Research and the Richard A. Moggio, MD Student Research Fellowship for their 


















Table of Contents 
Section    Page   
Introduction    1 - 27 
Aims     27 
Methods    27 - 33 
Results    33 - 50 
Discussion    50 - 57 






	   1	  
Introduction 
Deep hypothermic circulatory arrest (DHCA) is a cerebral protection strategy that 
has been an integral part of cardiac and aortic surgery for decades. It has been especially 
important in advancing the feasibility of aortic arch operations, which entail unique 
challenges. At our institution, we have found DHCA to be a safe and effective cerebral 
protection method, and we employ DHCA in the vast majority of procedures involving 
the aortic arch. However, while we favor the use of DHCA, that is not the case at other 
institutions. A recent survey finds a variety of methods applied at expert institutions (1). 
While the benefits of DHCA are well established, potential shortcomings have been 
under debate—specifically if there are any negative effects on neurocognition and also 
how long can a patient be safely under DHCA.  
Thoracic Aortic Aneurysms 
 Approximately 10.4 per 100,000 people in the United States develop a thoracic 
aortic aneurysm (TAA) each year (2). TAA is a silent, but lethal, disease, with 95% of 
TAAs being asymptomatic before an acute event, such as dissection or rupture, occurs 
(3). Aortic aneurysms (both abdominal and thoracic) represent the 15th leading cause of 
death in individuals older than 55 years, and the 19th leading cause of death in individuals 
of all ages—so that aortic aneurysms cause more deaths in the United States than human 
immunodeficiency virus (HIV) (4). 
Natural History and Progression. The aneurysmal thoracic aorta grows in a 
generally indolent manner, increasing by about 1 mm each year. The average ascending 
aneurysmal aorta expands by 0.10 cm annually, with the descending thoracic aneurysmal 
aorta expanding at a slightly faster rate of 0.29 cm each year (5). Aneurysms with larger 
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diameters, however, tend to expand more rapidly. The annual growth rate for a 4.0 cm 
ascending TAA, for example, is 0.10 cm, while the annual growth rate for an 8.0 cm 
ascending TAA is 0.19 cm (6). The relationship between annual growth rate and 
aneurysm size is depicted in Figure 1. Dissected aortas also tend to grow more rapidly 
than non-dissected aortas (6). 
 
Figure 1. Absolute change in growth as a function of aortic size. Reprinted with 
permission from Coady et al (6). 
  
 There are subgroups of TAA patients in whom aneurysm growth rate is faster, and 
regular monitoring of aneurysm size is therefore even more crucial in avoiding 
potentially fatal complications such as dissection and rupture. One such subgroup is 
patients with familial TAAs. These patients’ TAAs grow at 0.21 cm/year (combined 
ascending and descending TAA) compared with patients with sporadic TAAs (7). Loeys-
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Dietz syndrome patients grow at an especially rapid rate, with their TAAs sometimes 
growing faster than 1.0 cm/year (7, 8).  
 Size of Aneurysm. In monitoring and managing TAAs, size has become the most 
important parameter to follow. In our Yale studies, we showed that the risk of natural 
complications, such as dissection or rupture or death, increases as TAAs get larger. In 
fact, we have been able to produce calculations of the annual risk of complications based 
solely on TAA size (Table 1) (9). Figure 2 graphically highlights the increase in risk of 
complications that corresponds with increasing TAA size.  
Table 1. Annual Risk of Complications Based on Thoracic Aortic Aneurysm Size 
 
Annual Risk (%) 
 
Aortic Size  Rupture Dissection Death  Rupture/Dissection/ 
                     Death 
 
> 3.5 cm  0.0  2.2  5.9   7.2 
> 4.0 cm  0.3  1.5  4.6   5.3 
> 5.0 cm  1.7  2.5  4.8   6.5 
> 6.0 cm  3.6  3.7  10.8   14.1 
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Figure 2. Annual risk of complications based on thoracic aortic aneurysm size.  
 
 Aortic dissection and rupture have approximately the same annual incidence of 
3.5 per 100,000 patients (10). Once dissection or rupture occurs, short-term and long-
term outcomes diminish rapidly. Data from the International Registry of Acute Aortic 
Dissection (IRAD) show that overall in-hospital mortality for acute thoracic aortic 
dissection is 27.4%. In-hospital mortality for acute type A dissections is about 35% (26% 
in patients undergoing surgical repair and 58% in patients managed non-surgically due to 
age or comorbidities) (11). In-hospital mortality for acute type B dissections is somewhat 
better at 12% (29%, 11%, and 10% for patients receiving surgical, endovascular, and 
medical management, respectively) (12). 
	   5	  
 Patients who have had dissected aortas have a severely compromised long-term 
outlook, as nearly 40% will suffer a fatal aortic rupture or require additional intervention 
(13). This is because, as mentioned above, previously dissected aortas expand at an 
accelerated rate (6). 
 The prognosis for TAA rupture is even worse than dissection. Johannson et al 
found that only 41% of patients with TAA rupture reach a hospital alive (14). For those 
patients lucky enough to make it to a hospital alive, the peri-operative mortality for 
surgical repair of the ruptured descending aorta is 28.6% and 23.4% for endovascular 
repair (15). 
 Our graphs and nomograms allow physicians to form a reasonable estimate of a 
specific patient’s risk of dissection, rupture, or death from the TAA for each future year 
of life if the aorta is not resected; this permits an evidence based decision on management 
of the TAA.  
Indications for Surgery. Our Yale studies have shown that once the aortic 
aneurysm has grown to a certain size, there is a dramatic increase in the risk of acute 
complications (rupture and dissection). In ascending aortic aneurysms, that “hinge point” 
is 6.0 cm, and in descending aortic aneurysms, the “hinge point” is 7.0 cm, as can be seen 
in Figure 3 (5). 
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Figure 3. Effect of aortic aneurysm size on cumulative, lifetime incidence of 
complications for the (A) ascending and (B) descending aorta. Reproduced with 
permission from Coady et al (5).  
 
It is important to note, however, that by the time the ascending aortic aneurysm 
reaches 6.0 cm, 31% of patients have already suffered a dissection or rupture of the 
aneurysm. By the time the descending aortic aneurysm reaches its “hinge point” of 7.0 
cm, 43% of patients have already suffered a dissection or rupture (9). A surgeon should 
therefore not wait until the aorta grows to its “hinge point” for intervention. Intervention 
should be made before the “hinge point” is reached. Elective surgical treatment of TAAs 
(very safe) is also highly beneficial to the patient over emergency surgical intervention 
(very dangerous). The 5-year survival rate after elective extirpation of a TAA is 
approximately 85%, achieving a survival curve approaching that of the healthy, age-
matched population. The 5-year survival rate after emergency surgical intervention, on 
the other hand, is only 37% (Figure 4) (16). 
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Figure 4. Kaplan-Meier survival curves after elective surgery, medical management, and 
emergency surgery for thoracic aortic aneurysms. Reproduced with permission from 
Davies et al (16). 
 
Surgical intervention before the “hinge point” aortic size is reached is therefore 
highly desirable, if possible. Our evidence-based recommendations for surgical 
intervention based on size are summarized in Table 2 (17, 18).  
Table 2. Thoracic Aortic Aneurysm Size Criteria for Elective Surgical Intervention 
 
  Non-Marfan’s  Marfan’s or Familial  Bicuspid Aortic Valve 
 
Ascending  5.5 cm   5.0 cm    5.0 cm 
Descending  6.5 cm   6.0 cm    N/Aa 
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aA bicuspid aortic valve increases the risk of dissection and rupture of an ascending 
thoracic aortic aneurysm, but not a descending aneurysm (18). 
 
Regardless of the size, though, all symptomatic aneurysms should be resected; the main 
symptom is pain consistent with the aneurysm location and unexplained by other causes. 
Rarely compression of adjacent organs (especially trachea, esophagus, or left main stem 
bronchus) may be the presenting symptom. Ascending aneurysm patients may experience 
congestive symptoms due to aortic insufficiency caused by distraction of the aortic valve 
leaflets as the aorta expands (19). Aneurysmal growth rate of ≥ 1 cm/year (rare with 
proper measurement techniques (20)) or substantial growth with the aneurysm rapidly 
approaching the size criteria listed in Table 2 are also valid indicators for which we 
would recommend surgical intervention (19). 
DHCA 
History Behind DHCA as a Cerebral Protection Strategy. The concept of using 
hypothermia for organ preservation was not applied to cardiac surgery until the mid-20th 
century when a few innovative and courageous surgeons discovered the usefulness of 
deep hypothermia in surgery. The DHCA era began in 1952, when what is probably the 
world’s first successful open-heart surgery was performed by American cardiac surgeon 
John Lewis, who used systemic hypothermia with no cardiopulmonary bypass in his 
closure of a secundum-type atrial septal defect (21).   
 Across the Atlantic Ocean in England, another cardiac surgeon was also paving 
the way for the use of hypothermia in cardiac surgery. In 1957, Charles Drew began 
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experimenting with the use of hypothermia in dogs. He found that it was possible to cool 
a dog down to 15°C, turn off cardiopulmonary bypass, keep the dog under circulatory 
arrest for 30 minutes, and then rewarm it with a subsequently normal heart rhythm. Based 
on these pioneering animal experiments, Dr. Drew applied the technique in humans. 
Called at that time the “Drew technique,” hypothermia was applied by Dr. Drew in 
operations on both infants and adults until his retirement in 1981 (22). 
 Going further East, a cardiac surgeon was exploring the use hypothermia in 
cardiac surgery in the mid-20th century. Professor Eugene N. Meshalkin worked in 
central Siberia, where snow and ice were more than abundant. In the 1960s. He began 
using the snow and ice as topical hypothermic agents to cool patients down to 28 to 29°C. 
Using this technique, he operated on ventricular septal defects, atrioventricular canals, 
and other congenital pathologies. It has been reported that he even operated on tetralogy 
of Fallot cases and replaced mitral and aortic valves with hypothermia without 
cardiopulmonary bypass (23, 24).  
 While the 1950s saw the start of the use of hypothermia in cardiac surgery, it 
would still be another decade until hypothermia found its way into aortic surgery. In 
1963, Barnard and Schrire introduced the use of hypothermia in thoracic aortic surgery, 
describing three cases involving the aortic arch where profound hypothermia was used 
during surgery (25). In these pioneering efforts, two patients died on the table or post-
operatively, but one was discharged from the hospital in good condition.  In the mid-
1970s, Randall Griepp validated the use of hypothermia for cerebral protection, 
publishing additional successful operations in which hypothermia was used for cerebral 
protection against ischemic injury during aortic arch replacement surgery (26). Based on 
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Griepp’s exceptional clinical and scientific studies, hypothermia for aortic surgery 
became a widely used and accepted method for cerebral protection during aortic arch 
operations. More recently, other cerebral protection strategies have also been developed 
and promoted, namely antegrade cerebral perfusion (ACP) and retrograde cerebral 
perfusion (RCP). Many centers have adopted these new techniques in lieu of 
hypothermia. However, which method—deep hypothermia, ACP, or RCP—is actually 
the most effective and safest has been, and still is, under hot debate.  
Science Behind DHCA. The brain is particularly susceptible to ischemic injury 
due to its high metabolic rate of oxygen and glucose consumption, which is several times 
faster than other organs (27). Though the brain only accounts for approximately 2% of 
total body weight, it accounts for 20% of the resting total body oxygen consumption and 
receives 15-20% of the cardiac output (28). Unlike other tissues, the brain does not have 
stored glucose reserves, so that any interruption of blood flow has an immediate impact 
on neuronal function (27). 
 DHCA is able to protect the brain from ischemic injury in a number of ways, one 
of which is by lowering the brain’s high metabolic rate. It is well established that 
hypothermia significantly decreases global cerebral metabolic rate for glucose and 
oxygen. It has been shown that for every 1°C drop in body temperature, cellular 
metabolism decreases by an average of 5 to 7% (29, 30). Therefore, at 18°C, cellular 
metabolic rate is only 12 to 25% of the metabolic rate at normal body temperature 
(Figure 5) (31).  
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Figure 5. Decrease in cerebral metabolic rate with decreasing body temperatures. 
Reprinted with permission from Kirklin JW et al. (31). 
 
Another useful rule of thumb is that metabolism of any cell, tissue, organ, or organism 
decreases exponentially as temperature falls—by 50% for every 6o C drop in temperature 
(32). Hypothermia decreases anaerobic metabolism, and decreases lactic acid generation. 
These effects minimize neuronal damage and necrosis that would otherwise have been 
caused by the acidosis created by the excess lactic acid production (29). 
 Hypothermia also significantly reduces temperature-dependent release and 
extracellular levels of excitatory neurotransmitters such as glutamate, a N-methyl-D-
aspartate (NMDA) receptor agonist. NMDA receptor activation leads to the unfavorable 
release of calcium ions, which then enter cells and accumulate. This leads to activation of 
intracellular proteases and mitochondrial dysfunction, resulting ultimately in neuronal 
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cell death. Hypothermia reduces NMDA receptor activation, thus significantly decreasing 
calcium ion release and preventing irreversible neuronal injury (33). 
 Hypothermia provides cerebral protection also by reducing neuronal apoptosis, 
decreasing the release of pro-apoptotic proteins such as caspases and bcl-2, and by 
interfering in pro-apoptotic pathways such as the mitogen-activated protein kinase 
pathway. Hypothermia also significantly reduces free radical release after neuronal 
damage and decreases the production of inflammatory cytokines. Yet another way that 
hypothermia protects the brain from ischemic injury is by reducing post-ischemic 
cerebral edema by decreasing disruption of the blood-brain barrier and damage of 
endothelial vasculature after ischemia (33).  
Overall, the protection of tissues by hypothermia reflects a panoply of powerful 
and wide-ranging beneficial effects. Simply put, there is no better protection against 
ischemic injury than hypothermia. 
Comparison with Antegrade and Retrograde Cerebral Perfusion. Since DHCA 
was first used as a cerebral protection method in aortic arch surgery in the 1960s by Drs. 
Barnard and Schrire (25), other strategies for cerebral protection have been developed, 
including ACP and RCP. Besides DHCA, these are two of the most commonly used 
cerebral protection techniques during interventions on the aortic arch. There is 
considerable debate about which of these three strategies offers superior cerebral 
protection (34-36). We present here a summary of currently published data from large 
studies that either describe their experience with one technique or compare outcomes 
with different techniques (specifically, stroke and mortality rates) (Table 3).  
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Table 3. Review of pertinent literature on post-operative outcomes of straight deep 










Retrograde Cerebral Perfusion  
Safi, 1993 (37) 11 0 9.1  
Ueda, 1994 (38) 33 12.1 6.1  
Deeb, 1995 (39) 35 8.6 2.9  
Lytle, 1995 (40) 43 9.3 9.3  
Ueda, 1999 (41) 249 10 4 Retrospective 
Ogino, 2001 (42) 28 0 3.6 Type A dissections 
Bavaria, 2002 (43) 163 9.8 3.0  
Appoo, 2006 (44) 79 7.6 3.8 Confined to elective cases 
Antegrade Cerebral Perfusion 
Matsuda, 1989 (45) 34 9.0 2.9  
Bachet, 1991 (46) 54 13.0 1.8  
Ando, 1994 (47) 42 7.1 7.0 Type A dissections (acute and 
chronic) 
Kazui, 1994 (48) 80 16.3 1.3  
Tabayashi, 1994 (49) 77 19.4 5.0  
Kazui, 2000 (50) 220 12.7 3.3  
Di Eusanio, 2002 (51) 403 9.4 3.7  









Bachet, 2002 (52) 206 17 4.5 Rate of non-fatal strokes 6% 
Kazui, 2007 (53) 472 9.3 3.2 Probably includes patients from 
studies in 1994 (50), 2000 (38) 
Khaladj, 2008 (54) 501 11.6 9.6 9.6% PND, 13.4% TND. 
Multivariate analysis relates PND 
to renal insufficiency 
Ogino, 2008 (55) 531 4.0 2.9 Retrospective 
Toyama, 2009 (56) 26 3.8 7.7  
Krahenbuhl, 2010 (57) 280 4.0 7.5 Mortality and stroke rates in 
patients with mean circulatory 
arrest time >40 min 6.8% and 
13.7% respectively 
Leshnower, 2010 (58) 412 7.0 3.6 Retrospective 
Minakawa, 2010 (59) 122 8.2 4.1  
Zierer, 2011 (60) 245 8.0 6.0 Retrospective, ACP combined 
with mild HCA 
Numata, 2012 (61) 164 6.1 7.9 Retrospective 
Deep Hypothermic Circulatory Arrest 















7.0 DHCA > 45 min correlated with 
stroke 
DHCA > 65 min correlated with 
death 











DHCA > 40 min correlated with 
(embolic) stroke 
Comparison studies 
Deep Hypothermic Circulatory Arrest and Antegrade Cerebral Perfusion 













Compared straight DHCA to ACP 
 











No comparisons of DHCA vs ACP 
were statistically significant 















ACP = 8.8 
Overall 
= 4.3 
Retrospective; method of 
randomization to groups is 
unclear; 61% of DHCA group 
patients had emergent operations 
compared to 32% of the ACP 
group; DHCA stroke rate for 
elective cases was 0 











Retrospective. Results from 44 
different centers. All patients with 
Type A dissections 
     
 
Deep Hypothermic Circulatory Arrest and Retrograde Cerebral Perfusion 
Safi, 1997 (68) DHCA = 
41 






RCP = 3 
Retrospective study with large size 
discrepancy between groups;  
Wong, 1999 (69) DHCA = 
34 






Nonrandomized; RCP was not 
protective against for mortality or 
stroke. 























Retrospective case control; no 
statistically significant difference 
in mortality or stroke between 
groups. 




RCP = 50 
DHCA = 
20.0 





Retrospective; large size 
discrepancy between patient 
groups 
Harrington, 2003 (72) DHCA = 
18 
RCP = 20 
DHCA = 
5.5 
RCP = 5.0 
Overall 
= 2.6 
Prospective randomized trial to 
evaluate effect of procedure 
neuropsychometric outcomes; no 
difference found between groups 











Retrospective, a trend towards 
reduced mortality and stroke in the 
RCP group found 
Antegrade Cerebral Perfusion and Retrograde Cerebral Perfusion 









Okita, 2001 (74) 
 




RCP = 6.6 







No straight DHCA patients; only 
difference found was higher 
incidence of transient brain 
dysfunction in RCP patients. 
Apostolakis, 2008 
(75) 
RCP = 25 
ACP = 
23 
RCP = 16.6 





All patients with type A acute 
dissections. No significant 
difference in mortality or stroke. 




RCP = 2.8 






RCP and ACP conducted in two 
different institutions. Arch 
reconstruction period no longer 
that 45 minutes in all cases.  
aEstrera, 2010 (77) RCP = 34 
ACP = 
30 
RCP = 9 
ACP = 20 
RCP = 2 
ACP = 
13 
A select group of patients 
requiring extended hypothermic 
circulatory arrest (>40 min) 




RCP = 4.1 





Retrospective. No significant 
difference between mortality or 
stroke rates. 









Deep Hypothermic Circulatory Arrest and Antegrade Cerebral Perfusion and Retrograde 
Cerebral Perfusion 
Svensson, 2001 (79) DHCA = 
10 
RCP = 10 
ACP = 
10 
DHCA = 0 
RCP = 0 
ACP = 0 
DHCA 
= 0 
RCP = 0 
ACP = 
0 
Prospective randomized controlled 
study. Neurocognitive results 
demonstrate superiority of DHCA 
in long-term outcome. 










RCP = 0 







Retrospective; no significant 
differences in mortality or stroke 
rate among groups 
Sundt, 2008 (81) DHCA = 
220 
RCP = 53 
ACP = 
74 
DHCA = 7 
RCP = 17 
ACP = 8 
DHCA 
= 9 
RCP = 9 
ACP = 
5 
Study showed superiority of ACP 
for total arch replacements only; 
overall results show no superiority. 









Apaydin, 2009 (82) DHCA = 
48 








RCP = 1 
ACP = 
10 
Retrospective. No significant 
difference in mortality or stroke 
between the perfusion groups. 
Forteza, 2009 (83) DHCA = 
32 





RCP = 23 







Retrospective. All patients with 
type A acute dissections. No 
significant difference in mortality 
or stroke between groups. 












Retrospective, 38% of the non-
ACP group had RCP as an adjunct 
to DHCA. Mortality rates not 
significantly different. 
Misfeld, 2012 (85) DHCA = 
220 











No statistical difference in 
mortality rates between groups. 
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aIn this study patients with ACP received brief RCP before terminating DHCA 
ACP = antegrade cerebral perfusion; DHCA = deep hypothermic circulatory arrest; PND 
= permanent neurologic deficit; RCP = retrograde cerebral perfusion; TND = temporary 
neurologic deficit. Reprinted with permission from Ziganshin BA, et al (86). 
 
The data from these studies show very similar stroke and mortality rates when 
using DHCA, ACP, or RCP. The small and inconsistent differences in outcomes are not 
surprising and likely related to patient selection, disease complexity, and institutional 
variations (such as extent of surgical experience with a technique). This shows that all 
three techniques are relatively safe and effective cerebral protection methods, and the 
choice of which technique to use depends on institutional preference. 
While DHCA, ACP, and RCP have similar stroke and mortality rates, there are 
still important differences in the pros and especially the cons between the three 
techniques. Of the three, RCP is becoming the least popular due to increasing evidence 
that very little oxygen actually reaches the brain via venous perfusion because of venous 
valves, whose purpose is to prevent exactly what RCP is trying to achieve. Also much of 
the retrograde perfusion is diverted via collaterals and never reaches the brain, but rather 
is wasted on the soft tissues of the head and upper chest wall (87, 88). The positive 
outcomes attributed to RCP (36, 41, 42, 73, 78) may therefore arise from non-oxygen 
carrying properties. One major advantage of RCP is that it flushes embolic debris out of 
the arterial circulation system and reduces the incidence of air emboli (37). However, our 
clinical experience and studies have shown that patients with aortic root aneurysms are 
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protected against arteriosclerosis (89, 90), and so debris is not frequently a problem. 
Also, DHCA allows for a bloodless and uncluttered field with wide-open exposure of the 
aorta, which permits the surgical team to visualize and capture any debris liberated during 
aortic debridement and preparation of aortic cuffs for anastomoses (91). DHCA is 
therefore intrinsically conducive towards avoiding embolization.  
Unlike RCP, which has decreased in popularity, ACP has markedly increased in 
popularity in recent years. ACP makes good sense, as it delivers oxygen-rich blood to the 
brain, and is the most similar to physiological brain perfusion of the three cerebral 
protection techniques. There are, however, several important issues with using ACP, one 
of which regards how many vessels should be perfused during ACP, on which there is no 
consensus. This is a crucial issue, as adequate and balanced perfusion of all brain 
structures is the cornerstone of effective cerebral protection. Some institutions prefer to 
perfuse all three of the head vessels (59, 61), including the left subclavian artery, while 
others prefer to perfuse just the right axillary and left common carotid artery (50, 60). 
Still other institutions believe that unilateral perfusion (innominate artery only) is 
sufficient (58, 66, 92).  
The other extremely important issue with ACP is that there is no standardization 
of appropriate flow rates. Many centers use 8-10 cc/kg/min, which may well be 
excessive. High flow rates have been demonstrated to cause cerebral edema (93) and low 
flow rates result in cerebral hypoperfusion, defeating the purpose of ACP. ACP can 
therefore cause significant cerebral damage, as the balance between hypo- and 
hyperperfusion has yet to be optimized. Other issues with the use of ACP include the 
potential to cause catheter-induced trauma to head vessels, which are often fragile or 
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themselves affected by dissection. Embolization, both air and particulate, is another 
danger with using ACP. Particulate embolism is of particular concern, as debris may be 
liberated during catheter introduction. All these issues raise concerns about the use of 
ACP, especially during emergency cases, such as acute aortic dissections, where there is 
little time to spare on establishing a sophisticated perfusion system of the brain. 
DHCA, on the other hand, avoids all the previously mentioned concerns with both 
RCP and ACP, as well as provides a bloodless and uncluttered field with no intrusive 
clamps or perfusion cannulae (31). And, unlike ACP, DHCA is especially appropriate in 
emergency situations where time is of the essence and the simplicity of DHCA allows for 
immediate life-saving procedures while providing good cerebral protection. DHCA does, 
however, raise the issue of how much time under DHCA is safe, on which there is no 
consensus as of yet. Some studies have found 20 to 25 minutes to be the safe upper limit 
of time under DHCA (65, 94-96), while in our previous studies, we have found that upper 
limit to be 40 minutes or more (63). 
All in all, DHCA, ACP, and RCP have comparable results in terms of stroke and 
mortality rates, with each technique entailing its own set of pros and cons. The choice of 
technique is ultimately based on each surgeon’s preference and comfort level. We invited 
all members of the Editorial Board of the new journal AORTA (members are listed on 
the journal website http://aorta.scienceinternational.org) to fill out an online survey in 
which they were asked: which method of cerebral protection do you favor during aortic 
arch surgery? The choices they were given were: (1) DHCA; (2) selective ACP; (3) RCP; 
(4) DHCA, or cerebral perfusion depending on case complexity. 29 board members 
responded with the results shown in Figure 6.  
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Figure 6. Pie chart of AORTA Editorial Board members’ preferences in terms of cerebral 
protection during aortic arch surgery. Note that almost half of the cardiac surgeons (more 
than those with a preference of ACP) responded with a preference of using DHCA (either 
alone or with a cerebral perfusion technique depending on the case complexity). 
Reprinted with permission from Ziganshin BA (1). 
 
The responses reflect current trends in cerebral protection strategy, with ACP being the 
most popular among the surgeons polled (45%) and RCP being the least (7%). It is 
interesting, however, to note that almost half of the surgeons (48%), more than those 
stating a preference for ACP, preferred using either DHCA or choosing between DHCA 
and a cerebral perfusion technique depending on case complexity (1). 
Neurocognitive Effects. While the advantages of DHCA are largely undisputed, 
there are many conflicting studies on DHCA-related detrimental effects, especially 
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neurocognitive. Of the three most commonly used cerebral protection methods, antegrade 
cerebral perfusion (ACP), retrograde cerebral perfusion (RCP), and DHCA, Svensson et 
al found all 3 to be equivalent in terms of brain injury (by looking at levels of brain injury 
markers), but found DHCA to be the superior method in preserving neurocognitive 
function (79). We previously published a retrospective clinical study looking at mortality 
and post-operative neurological complications that showed using DHCA as the sole 
means of cerebral protection is both effective and neurologically safe (63). In another 
retrospective study, we showed that in patients with high cognitive needs for their 
professions, DHCA had no adverse effect on their reported cognition or work 
performance (97). A number of other studies, however, have found DHCA to have a 
negative impact on neurologic function (65, 72, 94, 98, 99).  Some studies also report a 
cutoff time of 20 to 25 minutes under DHCA, above which neurologic deficits may 
appear (65, 94-96). 
Also, while it is well established in the literature that memory is commonly 
negatively affected after cardiac surgery (100, 101), any long-term effects that DHCA 
may have on neurocognition, and memory in particular, are relatively unknown. There 
have been multiple studies on the temporal nature of neurocognitive deficits incurred 
post-operatively in coronary artery bypass graft (CABG) patients. There is some 
controversy about the persistence of deficits incurred post-operatively, with some studies 
showing the deficits incurred shortly after surgery to persist (102-104), with other studies 
showing that deficits resolve in the long term (105, 106). However, when it comes to the 
temporal nature of memory deficits incurred after thoracic aortic aneurysm surgery and 
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also DHCA, there is a dearth of literature, with only one study to the author’s knowledge 
following patients beyond the first follow-up visit at 4 to 6 weeks (72). 
Most studies on the neurocognitive effects of DHCA in adults have been 
retrospective with either only gross assessment of neurologic function, only qualitative 
assessment, or quantitative tests administered only post-operatively. There have been 
very few studies that quantitatively measured changes in neurocognitive function based 
on scores of tests administered both pre and post-operatively, and even fewer studies that 
have followed patients longitudinally past the first post-operative follow-up visit at 4 to 6 
weeks. That is precisely the type of study we present here. 
We studied patients undergoing only ascending aortic replacement (without 
approach to the aortic arch), who did not require DHCA, as a control group. We 
compared their function to patients undergoing ascending and arch surgery, our DHCA 
group. Thus, both groups were exposed to cardiac surgery and aortic surgery and their 
general effects. In fact, this comparison is likely to bias against DHCA, as the DHCA 
operations were more extensive and complicated.  
A battery of neuropsychometric tests was administered to 62 patients—33 
undergoing surgery without DHCA, and 29 undergoing surgery with straight DHCA 
(DHCA as the only method used for cerebral protection)—once pre-operatively and then 
post-operatively at the first post-operative follow-up visit and again months to a few 
years after the after surgery (4.5 months to almost 3 years) with the tests administered 
focusing on the areas of memory and processing speed, as those are the two cognitive 
domains that have most commonly been shown to be vulnerable for patients undergoing 
DHCA (72, 79, 94, 98). We also take a more in depth look at memory, examining 
	   27	  
multiple aspects, instead of accepting a general effect as other studies have done. In 
addition, we included in our assessment battery the Clock Drawing Test (CDT), which is 
very sensitive for detecting deficits in global cognitive function, executive functions, as 
well as the integration of many advanced cortical functions (107).  
 
Aims 
We hope to determine if there are any differences in neuropsychometric test 
scores between the pre-operative testing and the post-operative testing, both within the 
DHCA and non-DHCA groups and between them. We hope also to determine the 
temporal nature of any negative effects that DHCA may have on neurocognitive function.  
  
Methods 
This study was approved by the Yale University School of Medicine Human 
Investigative Committee (number 1210010969). 
Patient Population 
Patients who were scheduled for surgical repair of an ascending aortic or aortic 
arch aneurysm between July 2010 and February 2013 were asked to participate in this 
study. Of the 62 total patients enrolled in this study, 29 underwent straight DHCA and 33 
did not require DHCA.  
In the DHCA group, there were 23 males and 6 females. Mean age was 64.5 years 
with a range of 43 to 79 years. 1 patient had Marfan syndrome, and 1 had Loeys-Dietz 
syndrome. 2 patients underwent surgical repair for chronic Type A aortic dissections. 11 
underwent root-sparing procedures (7 with aortic valve replacement, 4 without aortic 
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valve replacement), and 18 underwent root replacement procedures. For the distal 
anastomoses, 24 patients had hemiarch replacements and 5 had total arch replacements. 
Mean duration under DHCA was 28.2 minutes with a range of 20 to 54 minutes. 
In the control group of 33 patients who did not undergo DHCA, there were 27 
males and 6 females. Mean age was 58.6 years with a range of 36 to 75 years. There were 
no Marfan or Loeys-Dietz syndrome patients. There were no Type A aortic dissection 
repairs. 6 patients underwent root-sparing procedures (4 with aortic valve replacement, 2 
without aortic valve replacement), and 27 underwent root replacement procedures. There 
were no arch resections in this group. 
All 62 patients who entered into this study survived surgery with no post-
operative strokes or seizures. 
In the follow-up study looking at the temporal nature of effects that DHCA had on 
neurocognition, the patients consisted of those from the first study who tested positive for 
memory deficits based on their neurocognitive testing scores, 11 of whom were in the 
DHCA group and 13 of whom were in the non-DHCA group. 5 of these patients, 3 in the 
DHCA group and 2 in the non-DHCA group, declined further testing and were therefore 
excluded from this follow-up study. 
Among the patients completing the follow-up study, in the DHCA group, there 
were 6 males and 2 females. Mean age was 65.9 years with a range of 52 to 78 years. 
There were no patients with Marfan syndrome or Loeys-Dietz syndrome. 1 patient 
underwent surgical repair for chronic Type A aortic dissections. 3 underwent root-sparing 
procedures (2 with aortic valve replacement, 1 without aortic valve replacement), and 1 
underwent a root replacement procedure. For the distal anastomoses, 4 patients had 
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hemiarch replacements and 4 had total arch replacements. Mean duration under DHCA 
was 33.8 minutes with a range of 20 to 54 minutes.  
Among the patients completing the follow-up study, in the control group of 11 
patients who did not undergo DHCA, there were 8 males and 3 females. Mean age was 
60.6 years with a range of 44 to 75 years. There were no Marfan or Loeys-Dietz 
syndrome patients. There were no Type A aortic dissection repairs. 1 patient underwent a 
root-sparing procedure without aortic valve replacement, and 1 underwent a root 
replacement procedure. There were no arch resections in this group. 
Deep Hypothermic Circulatory Arrest Management 
The surgical techniques for induction of deep hypothermia and use of circulatory 
arrest were constant for all patients. Total systemic perfusion is usually established by 
cannulating the femoral artery, unless the patient is shown to have arteriosclerotic disease 
of the descending aorta on intraoperative transesophageal echo or pre-operative computed 
tomography. If that is the case, the axillary artery is used for cannulation, or the aneurysm 
or distal aorta are cannulated directly. Venous return occurs via the right atrial appendage 
with a two-stage cannula (in very rare cases via the femoral vein), and carbon dioxide 
instillation into the surgical field is used in all cases. The extent of aortic resection is 
determined by the extent of the disease. The patient is put on cardiopulmonary bypass 
(CPB) and core cooling occurs. The head is packed in ice for topical cooling. No 
barbiturate coma is used during the operation. No electroencephalogram, sensory evoked 
potential, or jugular venous bulb oxygen saturation monitoring are used. No special 
glucose management techniques are applied. Deep hypothermic circulatory arrest 
management is by the Alpha-stat method. The mean core temperature (bladder) during 
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DHCA is 18.7°C with a range from 18 to 20°C. Rewarming, which usually takes about 
60 minutes, is taken to a temperature of 34 to 36°C. The non-DHCA patients are cooled 
to a mean temperature of 24.9°C. The maximum temperature gradient between perfusate 
and body temperature during rewarming is kept less than 10°C in order to prevent protein 
denaturation (63, 91). 
 For aortic arch reconstructions, the technique that we have used most commonly 
involves a two-vessel island with just the innominate and left common carotid arteries, 
instead of the traditional technique of creating a three-vessel Carrel patch (Figure 7).  
 
Figure 7. Aortic arch resconstruction methods. Traditional technique creating a three-
vessel Carrel patch (left) versus our preferred alternative technique creating a two-vessel 
Carrel patch. Reprinted with permission from Gega et al (63). 
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The left subclavian artery is re-attached using a small diameter graft either during 
rewarming or after termination of CPB. There are several advantages to using this 
technique, including an initially smaller Carrel patch suture line, allowing for less time to 
be spent under DHCA, and also excellent suture-line access for inspection and additional 
placement of hemostatic sutures if needed (63, 91, 108).  
Deep hypothermic circulatory arrest was used as the sole means of cerebral 
protection. Carbon dioxide flooding of the field was used in all cases. Extent of aortic 
resection was determined by the extent of disease, with the goal of excising all severely 
dilated aortic segments. 
Neurocognitive Tests 
A battery of neurocognitive tests was administered by a trained medical student, 
pre-operatively at either the office consultation visit or at the time of pre-admission 
testing, and post-operatively at the first follow-up visit. The mean time between pre and 
post-operative testing among the patients who underwent DHCA was 46.3 days with a 
range of 30 to 75 days, and among the patients who did not undergo DHCA the mean was 
45.2 days with a range of 31 to 77 days. The battery consisted of three tests that were 
chosen, and the results interpreted, with the help of a neuropsychometric specialist: Rey 
Auditory Verbal Learning Test (RAVLT), Trail Making Test (TMT)-A and B, and Clock 
Drawing Test (CDT). RAVLT tests multiple aspects of memory, including acquisition 
(sum of trials A1 through 5), learning rate (difference between trials A5 and A1), 
retention (trial A6), delayed recall (trial A7), and recognition (word list). TMT A and B 
test attention and processing speed. CDT tests advanced cortical executive functions and 
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their integration, as well as global cognitive function (107). “Neurocognitive deficit” was 
defined as greater than 20% decline in 2 or more tests (72). (We counted each aspect of 
memory that we tested as a separate test.)  
In the follow-up study, the RAVLT was administered again to patients months to 
years after surgery in order to reassess memory function. In the follow-up study, the 
mean time between pre and post-operative testing among the patients who underwent 
DHCA was 39.4 days with a range of 30 to 46 days, and among the patients who did not 
undergo DHCA the mean was 48.0 days with a range of 27 to 77 days. The mean time 
between post-operative and further follow-up testing among patients who underwent 
DHCA was 422.4 days with a range of 169 to 1033 days. Among the patients who did not 
undergo DHCA, the mean was 653.5 days with a range of 138 to 1089 days. 
Patients’ neurological function and status were assessed and tracked both pre and 
post-operatively by the intensive care unit and surgical teams. 
Statistical Analysis 
Very few studies have examined neuropsychometric test score changes after 
undergoing DHCA, and so there is no standardized sampling distribution for such score 
changes. Therefore, neither a reliable study power nor sample size could be calculated at 
the time of study design. However, our sample size of 62 is greater than the mean and 
median of the sample sizes of previous such studies, 55.8 and 57, respectively (72, 79, 
94, 96, 98). We also retrospectively calculated the sample size necessary to have a power 
of 0.8 with a Cohen’s d effect size of 0.8 and the p-values that we found using an on-line 
statistical sample size calculator (109). The samples sizes that were calculated were all 
smaller than the sample sizes used in each of our statistical tests.  
	   33	  
Analyses of dichotomous variables were done using Fisher’s exact test. Analyses 
involving continuous variables were done using the Mann-Whitney U test for data not 
normally distributed and student’s t test for normally distributed data. Normal distribution 
was assessed using Kolmogorov-Smirnov test. A repeated measures analysis of variance 
test was done to assess statistical significances of differences of test scores administered 
pre-operatively, post-operatively, and at further follow-up between groups and within 
each group. p-values less than 0.05 were considered significant. Statistical analyses were 
done using IBM SPSS Statistics software and were reviewed by Yale Center for 
Analytical Sciences. 
 The medical student was the primary person participating in all aspects of this 
project from study design to writing the IRB to enrolling patients and data collection to 
the statistical analyses of the data to the writing of the manuscripts for this study.   
 
Results 
Follow-up at 4-6 weeks post-operatively 
The demographic data and surgical characteristics for the non-DHCA and DHCA 
groups are presented in Tables 4 and 5, respectively, with no statistically significant 
differences between the two groups. Table 6 shows the means and standard deviations of 
pre and post-operative neuropsychometric test scores, and the means and standard 
deviations of the differences in scores (post minus pre-operative) for the non-DHCA 
group and the DHCA group. The means and standard deviations of the differences 
between post and pre-operative scores for each group are also depicted in Figure 8.  
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Table 4. Patient Demographics 
 
Variable    Non-DHCA  DHCA   p-value 
 
Total     33   29   
Sex           1.00 
    Male    27   23 
    Female    6   6 
Mean Age (range), y   58.6 (36-75)  64.5 (43-79)  0.08 
Mean Education (range), y  13.3 (8-18)  13.7 (8-18)  0.65 
Marfan syndrome   0   1   0.47 
Loeys-Dietz syndrome  0   1   0.47 
Stroke, pre-op    0   2   0.50 
Post-op neurologic events  0   0   1.00 
Pre to post-op test time (range), d 45.2 (27-77)  46.3 (30-75)  0.66 
 
DHCA = deep hypothermic circulatory arrest; post-op = post-operative; pre-op = pre-
operative. 
 
Table 5. Surgical Characteristics    
 
Variable    Non-DHCA DHCA  p-value 
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Duration DHCA (min), average 0  28.2     n/a 
Cooled temperature (°C), average 24.9  18.7  n/a 
Proximal anastomosis 
    Root-sparing   6  11   
        With valve   4  7  0.32 
        No valve    2  4  0.41 
    Root replacement   27  18  0.10 
    Valve-sparing   12  13  1.00 
Distal anastomosis       n/a 
    Hemiarch    0  24 
    Total arch    0  5 
Type A dissection repair  0  2  0.22 
Concurrent CABG   7  3  0.31 
Duration CPB (min), average  144.1  150.8  0.38 
Duration cross-clamp (min), average 104.3  96.6  0.18 
Post-operative hospital stay   5.88  5.97  0.91 
(days), average 
 
p-values were listed as n/a for characteristics that were specific to the DHCA group. 
CABG = coronary artery bypass graft; CPB = cardiopulmonary bypass; DHCA = deep 
hypothermic circulatory arrest. 
  
Table 6. Comparison of Mean Pre and Post-Operative Neuropsychometric Test Scores  
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Test    Pre-Op (SD) Post-Op (SD)    Difference (SD) p-value 
 
Memory    
RAVLT 
    Acquisitiona           
 Non-DHCA  40.82 (10.32) 38.18 (12.29)    -2.64 (7.21)  0.04 
 DHCA   37.52 (9.35) 34.52 (10.21)    -3.00 (4.46)  0.001 
 Non-DHCA vs DHCA       0.19 
    Learning Rateb           
 Non-DHCA  4.61 (2.66) 3.94 (9.61)    -0.67 (2.88)  0.19 
 DHCA   3.69 (1.97) 2.21 (4.40)    -1.48 (3.97)  0.054 
 Non-DHCA vs DHCA       0.07 
    Retentionb            
 Non-DHCA  8.18 (3.02) 7.09 (2.99)    -1.09 (1.72)  0.001 
 DHCA   7.31 (2.92) 6.28 (2.97)    -1.03 (0.94)  0.00 
 Non-DHCA vs DHCA       0.26 
    Delayed Recallb           
 Non-DHCA  8.27 (3.14) 7.30 (3.06)    -0.97 (1.61)  0.002 
 DHCA   7.48 (3.11) 6.45 (3.48)    -1.03 (1.18)  0.00 
 Non-DHCA vs DHCA       0.30 
    Recognitionb           
 Non-DHCA  4.61 (2.66) 3.94 (3.78)    -0.67 (2.12)  0.08 
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DHCA   3.69 (1.97) 2.21 (4.40)    -0.97 (1.30)  0.00 
Non-DHCA vs DHCA       0.63 
 
Processing Speed 
Trail Making Test-A (seconds)         
 Non-DHCA  41.88 (9.61) 40.91 (9.61)    0.97 (6.67)  0.41 
 DHCA   47.38 (16.66) 48.35 (17.07)    -0.97 (2.69)  0.06 
 Non-DHCA vs DHCA       0.07 
Trail Making Test-B (seconds)         
 Non-DHCA  91.30 (35.02) 91.91 (34.36)    -0.61 (9.86)  0.73 
 DHCA   101.79 (36.38) 102.41 (36.85)    -0.62 (4.18)  0.43 
 Non-DHCA vs DHCA       0.25 
 
Executive Function 
Clock Drawing Testc           
 Non-DHCA  9.70 (0.59) 9.70 (0.59)    0.00 (0.00)  n/a 
 DHCA   9.62 (0.62) 9.62 (0.62)    0.00 (0.00)  n/a 
 Non-DHCA vs DHCA       0.70 
 
aMaximum possible score of 65. bMaximum possible score of 15. cScored on a scale of 1 
through 10 using the system adapted from Sunderland et al (1989) and Libon et al (1993) 
(107). p-values of n/a were for comparisons of equal mean scores. For normative data, 
see Appendix. DHCA = deep hypothermic circulatory arrest; post-op = post-operative; 
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pre-op = pre-operative; RAVLT = Rey Auditory Verbal Learning Test; SD = standard 
deviation; vs = versus. 
 
 
Figure 8. Difference between post and pre-operative scores. Mean and standard deviation 
of the difference between post and pre-operative scores for the non-DHCA and DHCA 
groups. Note how similar the 2 groups are in all tests. DHCA = deep hypothermic 
circulatory arrest. 
 
Memory. In the non-DHCA group, in comparison to baseline pre-operative scores, 
there was a decline in post-operative scores seen in the memory areas of acquisition, 
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retention, and delayed recall. In the DHCA group, declines were seen in the same 
memory areas as seen in the non-DHCA group, but with the addition of recognition. 
There were, however, no differences between the non-DHCA and DHCA groups in the 
post versus pre-operative scores in any area of memory tested. 
Processing speed, executive function, global cognition. There were no declines 
seen in processing speed or executive function in either group. In comparing the post and 
pre-operative scores between the non-DHCA group and the DHCA group, there were no 
differences in any cognitive area tested. It is important to note that there were no changes 
in CDT scores post-operatively in all 62 patients, as any changes in CDT scores would 
have reflected a change in global cognitive function.  
“Neurocognitive deficit”. We also looked at the incidence of “neurocognitive 
deficit”, defined as a greater than 20% decline in 2 or more tests, and compared 
incidences between the non-DHCA and DHCA groups. In the non-DHCA group, 13 
patients incurred a “neurocognitive deficit”, and in the DHCA group 11 patients incurred 
a “neurocognitive deficit”. Through Fisher’s exact test, we found no difference in the 
incidence of “neurocognitive deficits” in the non-DHCA group versus the DHCA group 
(p = 1.00) (Figure 9A).  
In addition to assessing for differences in neurocognitive functions between 
patients who did or did not undergo DHCA, we also looked to see if there was any 
relationship between time under DHCA and incidence of “neurocognitive deficit”. Figure 
9B plots all the times under DHCA at which a “neurocognitive deficit” did or did not 
occur. Mean time under DHCA was 28.2 minutes with a range from 20 to 54 minutes. 
Using the Mann-Whitney U test, we found no difference in time under DHCA between 
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those who had a “neurocognitive deficit” versus those who did not (U = 82.50, Z = -0.75, 
p = 0.47). It is interesting, however, to note that all 3 patients who underwent DHCA for 
longer than 40 minutes experienced a “neurocognitive deficit”. 
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Figure 9. Incidence of “neurocognitive deficit”. (A) Number of patients in the non-
DHCA group and the DHCA group who experienced a “neurocognitive deficit”. (B) 
Scatterplot of the times under DHCA at which a patient did or did not experience a 
“neurocognitive deficit”. DHCA = deep hypothermic circulatory arrest. 
 
Follow-up months-years post-operatively 
The demographic data and surgical characteristics for the non-DHCA and DHCA 
groups are presented in Tables 7 and 8, respectively, with the only statistically significant 
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difference between the two groups being duration of cardiopulmonary bypass (CPB), 
with the DHCA group undergoing a longer duration of CPB.  
Table 7. Follow-Up Patient Demographics  
 
Variable    Non-DHCA  DHCA  p-value 
 
Totala         11   8   
Sex           1.00 
    Male        8   6 
    Female        3   2 
Mean Age (range), y       60.6 (44-75) 65.9 (52-78)  0.25 
Mean Education (range), y      13.6 (9-18)  13.6 (8-18)  0.90 
Marfan syndrome       0   0   1.00 
Loeys-Dietz syndrome      0   0   1.00 
Stroke, pre-op        1   0   1.00 
Post-op neurologic events      0   0   1.00 
Pre to post-op test time (range), d     48.0 (27-77) 39.4 (30-46)  0.09 
Post-op to follow-up test time     653.5 (138-1089) 422.4 (169-1033) 0.19 
 (range), d 
 
a24 patients had tested positive for memory deficits in the original study, but 5 declined 
any follow-up testing. Of the 5, 2 were non-DHCA patients and 3 had undergone DHCA. 
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DHCA = deep hypothermic circulatory arrest; post-op = post-operative; pre-op = pre-
operative. 
 
Table 8. Follow-Up Surgical Characteristics    
 
Variable    Non-DHCA  DHCA  p-value 
 
Duration DHCA (min), average  0  33.8     n/a 
Cooled temperature (°C), average  25.3  18.5  n/a 
Proximal anastomosis 
    Root-sparing    1  3  0.26   
        With valve    0  2  0.16 
        No valve     1  1  1.00 
    Root replacement    1  1  1.00 
    Valve-sparing    9  5  0.60 
Distal anastomosis        n/a 
    Hemiarch     0  4   
    Total arch     0  4 
Type A dissection repair   0  1  0.42 
Concurrent CABG    2  2  1.00 
Duration CPB (min), average   131.5  171.4  0.01 
Duration cross-clamp (min), average  97.0  110.1  0.12 
Post-operative hospital stay (days), average 5.18  5.25  0.30 
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p-values were listed as n/a for characteristics that were specific to the DHCA group. 
CABG = coronary artery bypass graft; CPB = cardiopulmonary bypass; DHCA = deep 
hypothermic circulatory arrest. 
 
Of the 19 patients who incurred memory deficits based on the post-operative 
testing and who agreed to participate in further follow-up neurocognitive testing months 
to years after their surgery (8 who underwent DHCA and 11 who did not), 6 continued to 
have memory deficits. 4 of those patients underwent DHCA and 2 did not (p = 0.32). 
While there was no statistically significant difference between patients who continued to 
have deficits who did or did not undergo DHCA, the patients in the non-DHCA group 
continued to have a greater than 20% decline in the same aspects of memory as they did 
at the 4 to 6 week post-operative testing, while of the 4 patients in the DHCA group, 3 
had a greater than 20% decline in additional memory aspects (Table 9).  
Table 9. Deficits in Specific Aspects of Memory 
 
  Acquisition Learning Retention Delayed Recognition 
        Rate      Recall 
 
Non-DHCA 
    Patient 1 
        4-6 weeks X        X           X        X 
        months-years X        X           X        X 
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    Patient 2 
        4-6 weeks         X           X  
        months-years         X           X 
 
DHCA 
    Patient 3 
        4-6 weeks         X           X 
        months-years         X          [X]        X 
 
    Patient 4 
        4-6 weeks         X 
        months-years            [X]    X 
 
    Patient 5 
        4-6 weeks X        X           X 
        months-years X        X          [X]        X   [X] 
 
    Patient 6 
        4-6 weeks X        X     
        months-years X        X 
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[X] signifies additional aspects of memory since the first post-operative testing that 
declined by greater than 20% from pre-operative scores. DHCA = deep hypothermic 
circulatory arrest. 
 
For all 3 patients, retention was an additional aspect of memory where a decline was seen 
at further follow-up. There was no statistically significant difference between the times 
under DHCA at which patients did or did not continue to have memory deficits (p = 0.56) 
(Figure 10). There was also no statistically significant difference in the days between 
surgery and the follow-up test in patients who did or did not have persistent memory 
deficits (p = 0.97). 
	   47	  
 
Figure 10. Time under DHCA and memory deficit resolution. Scatterplot of the times 
under DHCA which patients endured and whether their memory deficits resolved or 
persisted. 
 
There was a statistically significant difference between patients whose memory 
deficits persisted or resolved, and that was age. All 6 patients who had persistent memory 
deficits were greater than 70 years old (p < 0.001) (Figure 11).  
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Figure 11. Age and memory deficit resolution. Scatterplot of the age of patients and 
whether or not their memory deficits resolved or persisted. The dotted line marks 70 
years old and note that all patients who memory deficits persisted are over 70 years old. 
 
Table 10 shows the means and standard deviations of memory test scores at the pre-
operative, post-operative, and follow-up sessions for both DHCA and non-DHCA 
patients. When comparing test score across the 3 time points, there were statistically 
significant differences between patients under 70 years old and patients over 70 years old 
in all aspects of memory tested except in retention. 
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Table 10. Comparison of Follow-Up Mean Neuropsychometric Test Scores  
 
Test    Pre-Op (SD) Post-Op (SD)    Follow-Up (SD) p-value 
 
Memory    
RAVLT 
    Acquisitiona           
 < 70 years old  40.31 (10.40) 34.92 (11.09)    39.85 (11.67)   
 > 70 years old  33.00 (7.62) 23.17 (8.54)    22.50 (8.24)   
 < 70 vs > 70         0.02 
    Learning Rateb           
 < 70 years old  3.92 (1.71) 2.31 (4.17)    4.31 (1.49)   
 > 70 years old  3.00 (2.19) -2.17 (4.36)    -2.17 (4.58)   
 < 70 vs > 70         0.01 
    Retentionb            
 < 70 years old  7.77 (3.11)  5.69 (3.07)    8.00 (3.16)   
 > 70 years old  5.50 (2.35) 4.00 (1.67)    3.50 (1.64)   
 < 70 vs > 70         0.053 
    Delayed Recallb           
 < 70 years old  8.15 (3.08) 5.92 (3.09)    8.46 (3.28)   
 > 70 years old  5.17 (2.64) 3.17 (2.14)    3.33 (2.25)   
 < 70 vs > 70         0.02 
    Recognitionb           
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 < 70 years old  11.77 (2.01) 9.54 (1.94)    11.92 (2.06)   
 > 70 years old  9.50 (1.38) 7.67 (1.97)    7.17 (1.47)   
 < 70 vs > 70         0.003
 
aMaximum possible score of 65. bMaximum possible score of 15 (107). DHCA = deep 
hypothermic circulatory arrest; post-op = post-operative; pre-op = pre-operative; RAVLT 
= Rey Auditory Verbal Learning Test; SD = standard deviation; vs = versus. 
 
Discussion 
This study adds to the evidence that using straight DHCA for cerebral protection 
during ascending aortic surgery is effective in the preservation of neurocognitive function 
both in the immediate post-operative period and also long term.  
Follow-up at 4-6 weeks post-operatively 
Neurocognitive testing battery. We tested two of the most common cognitive 
domains thought to be negatively affected after undergoing DHCA, memory and 
processing speed, (72, 79, 94, 98) and took the domain of memory, which is often the 
most common cognitive domain to be affected after DHCA (96,110), and analyzed 
multiple aspects rather than treating it as one general cognitive function as other studies 
have done. We also included the Clock Drawing Test in our battery of tests, as this is a 
very sensitive indicator of global cognitive dysfunction and also assesses executive 
function along with the integration of many cognitive areas (107). In this way, we hoped 
to be able to catch any cognitive dysfunction that could be occurring that would not be 
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seen by administering only the Rey Auditory Verbal Learning Test and Trail Making 
Tests.  
Equal neurocognitive preservation as non-DHCA aortic surgeries. By comparing 
post-operative scores to the patients’ baseline pre-operative scores, we found no 
difference in any cognitive area tested between those who underwent DHCA and those 
who did not. We therefore show that patients who undergo aortic arch aneurysm surgeries 
using only DHCA for cerebral protection have the same level of neurocognitive 
preservation as those who undergo less extensive ascending aortic aneurysm surgeries 
without DHCA.  
Time under DHCA. On top of analyzing the effects of DCHA on neurocognitive 
function, we also looked at the relationship between time under DHCA and changes in 
neurocognition, as time under DHCA has been shown in other studies to be an important 
determinant of decline in neurocognitive function, with a cutoff time point cited between 
20 to 25 minutes (65, 94-96) or beyond 40 minutes (63). Defining a “neurocognitive 
deficit” as experiencing a greater than 20% decline from baseline in 2 or more tests based 
on a previous neuropsychometric study done by Harrington et al (72), we found there to 
be no relationship between incidence of “neurocognitive deficit” and time under DHCA 
(range of 20 to 54 minutes). However, we did notice that all 3 patients who were under 
DHCA for longer than 40 minutes experienced a “neurocognitive deficit”, so a larger 
study might reveal a statistical correlation with DHCA time. That would support our 
previous study, in which we found that time under DHCA for 40 minutes or longer leads 
to an increased risk of neurologic impairment (63). It is important to note that although 
we have applied the term “neurocognitive deficit”, based on the detailed 
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neuropsychometrics and clinical observations, these patients were in excellent clinical 
neurologic status, with no detectable clinical issues or abnormalities, or discernible 
impairments in daily life, school, or work. 
Memory. While we found no difference in the post versus pre-operative test 
scores between the non-DHCA group and the DHCA group, there was a decline in 
function seen in certain areas of memory post-operatively within both groups, namely 
acquisition, retention, and delayed recall. In the DHCA group, a decline in recognition 
was also seen. Processing speed and executive function were not affected. This finding 
that memory is negatively affected after cardiac surgery is not surprising, as this has been 
well established in the literature (100, 101). One possible mechanism behind this is in the 
metabolic nature of the hippocampus. The hippocampus plays a critical role in memory 
formation, but it has a high metabolic rate and so is particularly sensitive to ischemic 
injury (111-113). What is interesting, however, is that we found only specific aspects of 
memory to be affected after cardiac surgery, and also, that learning rate does not seem to 
be affected by cardiac surgery at all, in either the non-DHCA or the DHCA group. We 
were interested to know if the subtle alterations in measures of memory are durable or 
improve over time, as our testing was done relatively early after the surgical procedures 
(mean 36.4 days), and so we followed up with patients at a time-point of months to years 
after their surgeries.  
Follow-up months-years post-operatively 
DHCA Does Not Affect Recovery from Memory Deficits. In our previous study, 
we found that there was no difference between patients who underwent DHCA and those 
who did not in the occurrence of neurocognitive deficits incurred post-operatively. The 
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question then became: Are the deficits that were incurred short-term or long-term, and 
does undergoing DHCA affect the temporal nature of these deficits. In this study, 
following up with those patients who did test early-positive for memory deficits, with 
follow-up months to years post-operatively, we found no difference in terms of recovery 
from or persistence of memory deficits in patients who did or did not undergo DHCA. 
Time under DHCA was also found to have no effect on the resolution or persistence of 
memory deficits, confirming findings by Harrington et al, which was the one study that 
followed patients beyond 4 to 6 weeks (72). The time between surgery and further 
follow-up testing did vary among patients, but it was also found that there was no 
difference in the time between further follow-up testing and surgery in patients who did 
or did not recover from their memory deficits.   
Effects of Age. While DHCA was not found to affect the resolution or persistence 
of memory deficits incurred post-operatively, we found age to significantly affect the 
temporality of memory deficits. Specifically, whether a patient was over or under 70 
years old was found to be a significant difference between patients who did or did not 
recover from their memory deficits, with all 6 patients who were over 70 years old having 
persistent memory deficits.  
This finding is well-supported by the literature on both open heart surgeries and 
general surgeries, where it is well established that age is risk factor for post-operative 
cognitive decline, and that the elderly have a higher incidence of long-term post-
operative cognitive decline, with memory being the most commonly affected cognitive 
area (101, 114-117). The cause of this has to do with the fact that the brain of an elderly 
person is different from the brain of a younger person. Important differences include size, 
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distribution and type of neurotransmitters, metabolic function, and the capacity for 
plasticity (101).  
Memory Deficits in DHCA Patients that Persist Tend to Worsen. Although DHCA 
was found to have no significant effect on whether or not patients recovered from 
memory deficits incurred post-operatively, we did find that in patients who did have 
persistent memory deficits, those who underwent DHCA seemed to have declines in 
additional aspects of memory than what they manifested previously, particularly 
retention, while those who did not undergo DHCA had declines in the same aspects of 
memory as they did originally. It has previously been shown in 2 studies that in patients 
who undergo DHCA, poor neuropsychometric outcomes at early follow-up is a predictor 
of persistent poor outcomes at a later follow-up, with later follow-up occurring at 6 
weeks in one study and 12 to 24 weeks in the other (72, 96). Our study includes 
neuropsychometric follow-up 24 weeks to over 2 years post-operatively, and so we build 
upon previous studies by showing that if memory deficits persists past 24 weeks in 
patients who underwent DHCA, then in those patients, the deficits tend to worsen to 
affect additional aspects of memory. This leads to the question of why this occurs and 
further studies are needed to investigate the mechanism behind this finding. It should be 
emphasized that these deficits are subclinical—only elicited by detailed investigative 
testing, and manifested in only a very small subgroup of all patients undergoing DHCA. 
Limitations 
While there are no statistically significant differences in demographic data and 
surgical characteristics between the non-DHCA group and DHCA group, the nature of 
the indication for DHCA is such that those in the DHCA group were undergoing a more 
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extensive surgery (aortic arch involved), whereas in the non-DHCA group, the arch was 
not involved, and so there was no indication for DHCA. However, the fact that the non-
DHCA group patients underwent simpler and less extensive procedures should suggest 
that the non-DHCA group would experience a smaller decrease in scores post-operatively 
than the DHCA group. Since we found no difference in post versus pre-operative scores 
between the non-DHCA and DHCA groups, the less extensive surgical procedures 
undergone by the non-DHCA group lends strength to our findings. Also, while there was 
no statistically significant difference in the ages of the two groups, the average age of the 
non-DHCA patients (58.6 years) was younger than that of the DHCA patients (64.5 
years). In essence, despite biases against the DHCA group, brain preservation was still 
equivalent despite DHCA. 
Another limitation of our study was that we primarily focused on assessing the 
cognitive domains of memory and processing speed. There are other cognitive areas that 
could be assessed. However, we incorporated the CDT in order to compensate for other 
cognitive areas. CDT assesses executive function along with many other advanced 
cortical functions, as well as the integration of various functions. CDT is also very 
sensitive in detecting global cognitive dysfunction (107). We therefore believed the CDT 
to be an adequate test to detect cognitive areas besides memory and processing speed that 
may experience a deficit after DHCA.  
In this study, we showed that time under DHCA does not affect neurocognition. 
However, as mentioned previously, this study only had 3 patients who underwent DHCA 
for 40 minutes or longer, with most of the patients being under DHCA for less than 30 
minutes. We therefore recognize that our sample size for patients under prolonged DHCA 
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time was not very large. However, this study shows that longer DHCA times are rarely 
required even in a vigorous aortic practice. Our previous clinical study found a ceiling 
time of 40 minutes DHCA to be safe (63), while other studies have shown a time range of 
20 to 25 minutes as the upper limit of safe duration under DHCA (65, 94-96). Our mean 
and median DHCA times were 28.2 and 27 minutes, respectively, and only above 40 
minutes was any suspicion raised by the present study.  We feel we can confidently say 
that time under DHCA up to 25 minutes, and likely up to 40 minutes, does not negatively 
affect neurocognitive function. It is also important to remember that clinical, and likely 
sub-clinical, neurological dysfunction are multi-factorial, with air and particulate 
embolization playing a major role, especially in open aortic surgery (63). Those factors, 
of course, are technical and not directly related to DHCA duration.  
In terms of the long term follow-up portion of this investigation, that part of the 
study is limited by its small sample size, and we recognize that the cohort of patients 
participating in this study may not be representative of other patient populations, and that 
a study with a larger sample size may produce different results. However, our study is the 
only study to the author’s knowledge that investigates the effects of DHCA on the long-
term nature of memory deficits incurred post-operatively. Our study therefore provides 
important novel findings that will hopefully stimulate further studies in this area. 
Conclusions 
In conclusion, we augment evidence that using DHCA as the sole means of 
cerebral protection during ascending aortic surgery is effective at preserving 
neurocognitive function both in the short and long-term. Time under DHCA for less than 
40 minutes is found to not be an important contributor to quantitatively measured 
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neurocognitive outcome. In addition, we show that while DHCA does not affect whether 
or not memory deficits incurred post-operatively persist, what does affect the temporal 
nature of memory deficits is age, with patients over the age of 70 having a higher 
incidence of persistent long-term memory deficits. This study therefore shows that when 
considering the long-term neurocognitive outlook for aortic arch aneurysm patients, it is 
not the DHCA technique that comes into question, but the age of the patient. We do 
show, however, that whether by comparing raw scores or by comparing incidence of 
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